A Phase 1, Multicenter, Double-Blind, Placebo-Controlled, Randomized (Intra-Group) Clinical Trial to Evaluate Two Doses of Three Sequentially Escalating Cohort of Zika Virus Vaccine Inactivated (Adsorbed) (BBV121) in Healthy Adult Dengue Sero-Negative and Dengue Sero-Positive Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Zika virus vaccine (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- Sponsors Bharat Biotech
- 30 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 30 May 2017 New trial record